View Post

Doctors hope new breast cancer vaccine will save lives

In In The News by Barbara Jacoby

By: Brittany Jones From: actionnewsjax.com Part of a nearly $13.3 million Department of Defense grant will be used in our area to develop a vaccine for breast cancer. Currently, 280 patients are participating in the trial. Dr. Keith Knutson has been working with breast cancer patients for about ten years. “In addition to me being touched, the burden breast cancer …

Home test a new option for colon cancer screening

In In The News by Barbara Jacoby

From: cbsnews.com Colon cancer is the second leading cause of cancer deaths in the United States, but it doesn’t have to be. Now, a new, non-invasive home test for colon cancer will make screening more accessible to the millions of people who have avoided it. Colonoscopy is recommended once every 10 years for adults over the age of 50. However, …

Mayo Clinic offers at-home colon cancer screening test; critics cite concerns

In In The News by Barbara Jacoby

By Melissa Turtinen From: bringmethenews.com Minnesota-based Mayo Clinic is offering a new at-home test that its makers claim is a reliable alternative to the dreaded colonoscopy – although critics are raising questions about the costly new “breakthrough” product. Hospital officials announced Monday they’ll be among the first in the U.S. to offer the FDA-approved Cologuard test – a take-home, stool DNA test …

FDA gives clearance to proceed with clinical study – new drug candidate from Vivolux starves cancer cells

In In The News by Barbara Jacoby

Vivolux AB, a drug discovery company specialized in cancer treatment, announced today that the FDA has granted clearance to proceed with VLX600 into the clinical phase I/II. VLX600 is one of the company’s promising projects, and which was recently published in the journal Nature Communications. Researchers at Vivolux have discovered a novel cancer drug target. The drug candidate kills sleeping …

Scientists propose a breast cancer drug for bladder cancer patients

In In The News by Barbara Jacoby

From: MedicalXpress.com Researchers at Mayo Clinic have found amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC) and have shown that the presence of HER2 amplification is associated with particularly aggressive tumors. These findings suggest that administering trastuzumab to MPUC patients with HER2 amplification could improve outcomes, just …